Dynasil Corp of America (DYSL)
2.45
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 36.76M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 5.13% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.10 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 60.78% |
Profile
| Dynasil Corp of America is a USA based company. It operates in three segments. The Optics segment, which is the key revenue driver, encompasses Dynasil Fused Silica, Evaporated Metal Films, Hilger Crystals, and Optometrics. It manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, and optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Innovation and Development segment consists of the Radiation Monitoring Devices. The Biomedical segment consists of Dynasil Biomedical, a medical technology incubator that owns rights to certain early-stage medical technologies. |
| URL | https://www.dynasil.com |
| Investor Relations URL | N/A |
| HQ State/Province | Massachusetts |
| Sector | Information Technology |
| Industry | Electronic Equipment, Instruments & Components |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | Feb. 13, 2018 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 29, 2024 |
Ratings
Profile
| Dynasil Corp of America is a USA based company. It operates in three segments. The Optics segment, which is the key revenue driver, encompasses Dynasil Fused Silica, Evaporated Metal Films, Hilger Crystals, and Optometrics. It manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, and optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Innovation and Development segment consists of the Radiation Monitoring Devices. The Biomedical segment consists of Dynasil Biomedical, a medical technology incubator that owns rights to certain early-stage medical technologies. |
| URL | https://www.dynasil.com |
| Investor Relations URL | N/A |
| HQ State/Province | Massachusetts |
| Sector | Information Technology |
| Industry | Electronic Equipment, Instruments & Components |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | Feb. 13, 2018 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 29, 2024 |